Pharmacodynamics and pharmacokinetics of flunixin in the cat.
The non-steroidal anti-inflammatory agent (NSAID) flunixin was administered as single doses both orally and intravenously to six cats at a dose rate of 1.0 mg/kg in a two-part cross-over study. After oral dosing rapid absorption to a mean peak concentration of 2.586 micrograms/ml occurred at a mean time of 1.33 h. Similar mean plasma concentration-time AUC values for oral and intravenous dosing indicated that absorption by the former route was virtually complete. The decline in plasma concentration occurred fairly rapidly with both routes, and elimination half-life was approximately 1.0-1.5 h. The time course of inhibition of serum TXB2 concentration was similar for the two routes of administration, suggesting that similar dosing schedules are likely to be appropriate for evaluation of flunixin in clinical trials.
Lees
P
P
Department of Veterinary Basic Sciences, Royal Veterinary College, Hatfield, Herts.
Taylor
P M
PM
D000284:Administration, Oral; D000818:Animals; D002415:Cats / Q000378:metabolism*; D003002:Clonixin / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology; D005260:Female; D007275:Injections, Intravenous / Q000662:veterinary; D007408:Intestinal Absorption; D008297:Male; D013929:Thromboxane B2 / Q000037:antagonists & inhibitors* / Q000097:blood
D013929:Thromboxane B2; C014558:flunixin meglumine; D003002:Clonixin